Theravance Biopharma, Inc. (TBPH)
16.37
+0.03
(+0.18%)
USD |
NASDAQ |
May 22, 16:00
16.38
0.00 (0.00%)
After-Hours: 20:00
Theravance Biopharma Market Cap : 843.92M for May 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Viatris, Inc. | 19.39B |
| Relmada Therapeutics, Inc. | 738.43M |
| Indivior Pharmaceuticals, Inc. | 4.436B |
| Corcept Therapeutics, Inc. | 6.465B |
| Assertio Holdings, Inc. | 150.41M |
Market Cap Related Metrics
| PE Ratio | 7.425 |
| PS Ratio | 7.716 |
| Price to Book Value | 2.904 |
| Price to Free Cash Flow | 3.152 |
| Price | 16.37 |
| Earnings Yield | 13.47% |
| Operating PE Ratio | 9625.09 |
| Normalized PE Ratio | 7.262 |